Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy
出版年份 2021 全文链接
标题
Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-25
DOI
10.3389/fonc.2021.626818
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Avadomide monotherapy in relapsed/refractory DLBCL: Safety, efficacy, and a predictive gene classifier
- (2020) Cecilia Carpio et al. BLOOD
- PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors
- (2020) Minsuk Kwon et al. CLINICAL CANCER RESEARCH
- Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions
- (2020) Francesca Arruga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunotherapy of lymphomas
- (2020) Stephen M. Ansell et al. JOURNAL OF CLINICAL INVESTIGATION
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphatic endothelial cells prime naïve CD8+ T cells into memory cells under steady-state conditions
- (2020) Efthymia Vokali et al. Nature Communications
- Lymph node stromal cells: cartographers of the immune system
- (2020) Akshay T. Krishnamurty et al. NATURE IMMUNOLOGY
- A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma
- (2020) Fathima Zumla Cader et al. NATURE MEDICINE
- Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy
- (2020) Pei-Hsuan Chen et al. JCI Insight
- Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
- (2020) Alak Manna et al. Blood Advances
- Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy
- (2020) Nikolaos Ioannou et al. BLOOD
- Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
- (2020) Catherine S. Grasso et al. CANCER CELL
- Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles
- (2020) Nathan Dubois et al. Frontiers in Oncology
- Diagnostic and Therapeutic Potential of Extracellular Vesicles in B-Cell Malignancies
- (2020) Ernesto Gargiulo et al. Frontiers in Oncology
- Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
- (2019) Stephen M. Ansell et al. JOURNAL OF CLINICAL ONCOLOGY
- Translation control of the immune checkpoint in cancer and its therapeutic targeting
- (2019) Yichen Xu et al. NATURE MEDICINE
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
- (2019) Ziju Y. Xu-Monette et al. Cancer Immunology Research
- Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs
- (2019) Betul Gok Yavuz et al. Scientific Reports
- Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
- (2019) Daisuke Ennishi et al. Cancer Discovery
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T cell-inflamed phenotype
- (2019) James Godfrey et al. BLOOD
- PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
- (2019) Takahiro Kamada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer-associated fibroblasts—heroes or villains?
- (2019) Krystyna A. Gieniec et al. BRITISH JOURNAL OF CANCER
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
- (2019) Christina Claus et al. Science Translational Medicine
- T Cell Dysfunction in Cancer Immunity and Immunotherapy
- (2019) Anliang Xia et al. Frontiers in Immunology
- Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells
- (2019) Laia Gorchs et al. Frontiers in Immunology
- B-cell specific IRF4 deletion accelerates Chronic Lymphocytic Leukemia development by enhanced tumor immune evasion
- (2019) Daniela Asslaber et al. BLOOD
- Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
- (2019) Nicolas Jacquelot et al. CELL RESEARCH
- Genomic Analyses of PMBL Reveal New Drivers and Mechanisms of Sensitivity to PD-1 Blockade
- (2019) Bjoern Chapuy et al. BLOOD
- Increased frequency of CD4 + PD‐1 + HLA‐DR + T cells is associated with disease progression in CLL
- (2019) Lauren Elston et al. BRITISH JOURNAL OF HAEMATOLOGY
- Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
- (2019) Dhanya K. Nambiar et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of MYC in the transformation and aggressiveness of ‘indolent’ B-cell malignancies
- (2019) Daniel Filip et al. LEUKEMIA & LYMPHOMA
- Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
- (2019) Jong Yeob Kim et al. Cancers
- The immune landscape and response to immune checkpoint blockade therapy in lymphoma
- (2019) Justin Kline et al. BLOOD
- Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia
- (2018) Marina Wierz et al. BLOOD
- Mass cytometry of Hodgkin lymphoma reveals a CD4+exhausted T-effector and T-regulatory cell rich microenvironment
- (2018) Fathima Zumla Cader et al. BLOOD
- Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly
- (2018) A. Betsch et al. BLOOD REVIEWS
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- (2018) Roberta Zappasodi et al. CANCER CELL
- Survival of the fittest: Cancer challenges T cell metabolism
- (2018) Davide G. Franchina et al. CANCER LETTERS
- CD20-TCB with obinutuzumab pretreatment as next generation treatment of hematological malignancies
- (2018) Marina Bacac et al. CLINICAL CANCER RESEARCH
- Expression pattern of PD-L1 and PD-L2 in classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, and gray zone lymphoma
- (2018) Yosuke Tanaka et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- The opposing roles of CD4+ T cells in anti-tumour immunity
- (2018) Tomasz Ahrends et al. IMMUNOLOGY
- Chronic Lymphocytic Leukemia–Derived IL-10 Suppresses Antitumor Immunity
- (2018) Sara S. Alhakeem et al. JOURNAL OF IMMUNOLOGY
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
- (2018) Bjoern Chapuy et al. NATURE MEDICINE
- Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
- (2018) Joseph A. Fraietta et al. NATURE MEDICINE
- High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
- (2018) Carsten Krieg et al. NATURE MEDICINE
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
- (2018) Li Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity
- (2018) Elise Alspach et al. Cold Spring Harbor Perspectives in Biology
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression
- (2018) Diego Farinello et al. Nature Communications
- Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
- (2018) Matthew A. Lakins et al. Nature Communications
- Human Endothelial Cells Modulate CD4+ T Cell Populations and Enhance Regulatory T Cell Suppressive Capacity
- (2018) Wen Chean Lim et al. Frontiers in Immunology
- Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype
- (2018) Bastian Dörsam et al. Frontiers in Immunology
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma
- (2018) Natacha Bordry et al. OncoImmunology
- Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia
- (2018) Georg Aue et al. JOURNAL OF IMMUNOLOGY
- Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues
- (2018) Bola S. Hanna et al. LEUKEMIA
- T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
- (2018) Jonathan A. Trujillo et al. Cancer Immunology Research
- FAP delineates heterogeneous and functionally divergent stromal cells in immune-excluded breast tumors
- (2018) Viviana Cremasco et al. Cancer Immunology Research
- Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
- (2018) Alessandro Poggi et al. Frontiers in Immunology
- Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
- (2018) Megha Budhwani et al. Frontiers in Oncology
- B cell lymphomas present immunoglobulin neoantigens
- (2018) Michael S. Khodadoust et al. BLOOD
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- DNA repair defects and implications for immunotherapy
- (2018) Katherine M. Bever et al. JOURNAL OF CLINICAL INVESTIGATION
- Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
- (2018) Daisuke Ennishi et al. JOURNAL OF CLINICAL ONCOLOGY
- IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin
- (2018) Ryan S. Lane et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia
- (2018) Bola S. Hanna et al. LEUKEMIA
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer
- (2018) Emelie Rådestad et al. OncoImmunology
- Ibrutinib treatment improves T cell number and function in CLL patients
- (2017) Meixiao Long et al. JOURNAL OF CLINICAL INVESTIGATION
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
- (2017) Michael S. Khodadoust et al. NATURE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1
- (2017) N Cohen et al. ONCOGENE
- Type I Interferon in Chronic Virus Infection and Cancer
- (2017) Laura M. Snell et al. TRENDS IN IMMUNOLOGY
- Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
- (2017) Antje Sucker et al. Nature Communications
- Mesenchymal stromal cells promote B-cell lymphoma in lacrimal glands by inducing immunosuppressive microenvironment
- (2017) Min Joung Lee et al. Oncotarget
- Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma
- (2017) Zhi-Zhang Yang et al. Oncotarget
- The Role of the Bone Marrow Stromal Compartment in the Hematopoietic Response to Microbial Infections
- (2017) César Nombela-Arrieta et al. Frontiers in Immunology
- Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation
- (2017) Lothar C. Dieterich et al. Frontiers in Immunology
- Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
- (2017) Martina Musella et al. OncoImmunology
- Extracellular vesicles released by CD40/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells
- (2016) D. T. Smallwood et al. BLOOD
- Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy
- (2016) Kohei Tada et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma
- (2016) Colm Keane et al. CLINICAL CANCER RESEARCH
- Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
- (2016) Philippe Gascard et al. GENES & DEVELOPMENT
- T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
- (2016) Marzia Palma et al. HAEMATOLOGICA
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Interleukin-10: An Immune-Activating Cytokine in Cancer Immunotherapy
- (2016) Hui Zhang et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
- (2016) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis
- (2016) Nicolas Jacquelot et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
- (2016) Keisuke Kataoka et al. NATURE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- MYC regulates the antitumor immune response through CD47 and PD-L1
- (2016) S. C. Casey et al. SCIENCE
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)
- (2016) Cesarina Giallongo et al. Oncotarget
- The application of the fibroblast activation protein α-targeted immunotherapy strategy
- (2016) Guan-Min Jiang et al. Oncotarget
- T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
- (2016) Marzia Palma et al. HAEMATOLOGICA
- Classical Hodgkin Lymphoma with Reduced 2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
- (2016) M. G. M. Roemer et al. Cancer Immunology Research
- Regulatory T Cells: Differentiation and Function
- (2016) G. Plitas et al. Cancer Immunology Research
- Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts
- (2015) J. Paggetti et al. BLOOD
- A roadmap for discovery and translation in lymphoma
- (2015) D. M. Weinstock et al. BLOOD
- CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL
- (2015) P. R. Hagner et al. BLOOD
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- FDA Approval: Blinatumomab
- (2015) D. Przepiorka et al. CLINICAL CANCER RESEARCH
- Targeting the tumor vasculature to enhance T cell activity
- (2015) Evripidis Lanitis et al. CURRENT OPINION IN IMMUNOLOGY
- VEGF Overexpression Is a Valuable Prognostic Factor for Non-Hodgkin’s Lymphoma Evidence from a Systemic Meta-Analysis
- (2015) Jing Yang et al. DISEASE MARKERS
- From mice to humans: developments in cancer immunoediting
- (2015) Michele W.L. Teng et al. JOURNAL OF CLINICAL INVESTIGATION
- CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model
- (2015) T Kocher et al. LEUKEMIA
- Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition
- (2015) Leylah Drusbosky et al. LEUKEMIA RESEARCH
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Shaping of the tumor microenvironment: Stromal cells and vessels
- (2015) Marzenna Blonska et al. SEMINARS IN CANCER BIOLOGY
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas
- (2015) Murielle Grégoire et al. Oncotarget
- T Lymphocyte–Endothelial Interactions: Emerging Understanding of Trafficking and Antigen-Specific Immunity
- (2015) Christopher V. Carman et al. Frontiers in Immunology
- How does lenalidomide target the chronic lymphocytic leukemia microenvironment?
- (2014) A. P. Kater et al. BLOOD
- Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
- (2014) J. Reichel et al. BLOOD
- Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
- (2014) David D. W. Twa et al. BLOOD
- CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
- (2014) R. Jitschin et al. BLOOD
- Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
- (2014) Xuanming Yang et al. CANCER CELL
- Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy
- (2014) Christian P. Pallasch et al. CELL
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin’s lymphoma
- (2014) Z-Z Yang et al. LEUKEMIA
- Induction of thymic stromal lymphopoietin in mesenchymal stem cells by interaction with myeloma cells
- (2014) Shinji Nakajima et al. LEUKEMIA & LYMPHOMA
- Effector-Mediated Eradication of Precursor B Acute Lymphoblastic Leukemia with a Novel Fc-Engineered Monoclonal Antibody Targeting the BAFF-R
- (2014) R. Parameswaran et al. MOLECULAR CANCER THERAPEUTICS
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Mesenchymal Stromal Cells Support the Viability and Differentiation of Follicular Lymphoma-Infiltrating Follicular Helper T-Cells
- (2014) Michael T. Brady et al. PLoS One
- HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
- (2014) Daniel J. Kowalewski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- The two faces of IL-6 in the tumor microenvironment
- (2014) Daniel T. Fisher et al. SEMINARS IN IMMUNOLOGY
- Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation
- (2014) K. Heinig et al. Cancer Discovery
- Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
- (2013) J. Ruan et al. BLOOD
- Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells
- (2013) P. Greaves et al. BLOOD
- Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide
- (2013) A. G. Ramsay et al. BLOOD
- Protein Kinase C-β-Dependent Activation of NF-κB in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B Cells In Vivo
- (2013) Gloria Lutzny et al. CANCER CELL
- Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
- (2013) Christiane Meyer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interferon- Suppresses cAMP to Disarm Human Regulatory T Cells
- (2013) N. Bacher et al. CANCER RESEARCH
- Combining cancer immunotherapy and targeted therapy
- (2013) Antoni Ribas et al. CURRENT OPINION IN IMMUNOLOGY
- The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
- (2013) D. Brusa et al. HAEMATOLOGICA
- DNA repair genes are selectively mutated in diffuse large B cell lymphomas
- (2013) Noel FCC de Miranda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
- (2013) Eric Tran et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies
- (2013) M A Frassanito et al. LEUKEMIA
- Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
- (2013) G Comito et al. ONCOGENE
- Leukemia Mediated Endothelial Cell Activation Modulates Leukemia Cell Susceptibility to Chemotherapy through a Positive Feedback Loop Mechanism
- (2013) Bahareh Pezeshkian et al. PLoS One
- Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes
- (2012) F. Guilloton et al. BLOOD
- Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
- (2012) A. G. Ramsay et al. BLOOD
- Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
- (2012) Yibin Yang et al. CANCER CELL
- Blockade of Myeloid-Derived Suppressor Cells after Induction of Lymphopenia Improves Adoptive T Cell Therapy in a Murine Model of Melanoma
- (2012) K. N. Kodumudi et al. JOURNAL OF IMMUNOLOGY
- Stromal Endothelial Cells Establish a Bidirectional Crosstalk with Chronic Lymphocytic Leukemia Cells through the TNF-Related Factors BAFF, APRIL, and CD40L
- (2012) M. Cols et al. JOURNAL OF IMMUNOLOGY
- Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias
- (2012) Deepesh P. Lad et al. LEUKEMIA & LYMPHOMA
- Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review)
- (2012) GUANHUA SONG et al. ONCOLOGY REPORTS
- Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs
- (2011) A. Rehm et al. BLOOD
- The cooperating mutation or "second hit" determines the immunologic visibility toward MYC-induced murine lymphomas
- (2011) C. Schuster et al. BLOOD
- A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease
- (2011) D. Bagnara et al. BLOOD
- Aberrant interferon-signaling is associated with aggressive chronic lymphocytic leukemia
- (2011) J. Tomic et al. BLOOD
- Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance
- (2011) Marek Mraz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
- (2011) Madhavi Challa-Malladi et al. CANCER CELL
- CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2011) C. Zoglmeier et al. CLINICAL CANCER RESEARCH
- Physical contact with endothelial cells through 1- and 2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells
- (2011) R. Maffei et al. HAEMATOLOGICA
- Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3
- (2011) Xavier Badoux et al. HUMAN PATHOLOGY
- Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro
- (2011) Camilla A. Lindqvist et al. IMMUNOLOGY
- Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
- (2011) Bernhard Mlecnik et al. JOURNAL OF CLINICAL ONCOLOGY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Four types of Tregs in malignant lymphomas
- (2011) Jing Wang et al. Journal of Hematology & Oncology
- Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells
- (2011) P Amé-Thomas et al. LEUKEMIA
- High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma
- (2011) Qi-chun Cai et al. MEDICAL ONCOLOGY
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
- (2011) Christian Steidl et al. NATURE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions
- (2011) C. Taflin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia
- (2010) Y. Herishanu et al. BLOOD
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
- (2010) M. R. Green et al. BLOOD
- Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
- (2010) C. Xuan et al. BLOOD
- The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire
- (2010) B. Pourgheysari et al. BLOOD
- Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
- (2010) W. Ding et al. BLOOD
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
- (2010) Neta Erez et al. CANCER CELL
- Interaction with Vascular Endothelium Enhances Survival in Primary Chronic Lymphocytic Leukemia Cells via NF- B Activation and De novo Gene Transcription
- (2010) A. G. S. Buggins et al. CANCER RESEARCH
- TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy
- (2010) L. Yang CURRENT MOLECULAR MEDICINE
- Immune Regulation of Cancer
- (2010) Mary L. Disis JOURNAL OF CLINICAL ONCOLOGY
- Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
- (2010) Xiaoyuan Huang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease
- (2010) Giovanni D’Arena et al. LEUKEMIA RESEARCH
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
- (2010) Christian Steidl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harnessing the immune response to treat cancer
- (2010) H J Steer et al. ONCOGENE
- Macrophages as mediators of tumor immunosurveillance
- (2010) Siddhartha Jaiswal et al. TRENDS IN IMMUNOLOGY
- Chronic lymphocytic leukemia of E -TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression
- (2009) T. Enzler et al. BLOOD
- Functional Alteration of the Lymphoma Stromal Cell Niche by the Cytokine Context: Role of Indoleamine-2,3 Dioxygenase
- (2009) H. Maby-El Hajjami et al. CANCER RESEARCH
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Impaired interferon signaling is a common immune defect in human cancer
- (2009) R. J. Critchley-Thorne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling
- (2008) R. J. Byers et al. BLOOD
- Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)
- (2008) Kelly A. Cycon et al. EXPERIMENTAL HEMATOLOGY
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now